Girl presents after failed vision screening.
- Published in:
- Ocular Surgery News, 2024, v. 42, n. 10, p. 34
- By:
- Publication type:
- Article
Works matching IS 87503085 AND DT 2024 AND VI 42 AND IP 10
Results: 24
1
2
Correction.
- Published in:
- Ocular Surgery News, 2024, v. 42, n. 10, p. 4
- Publication type:
- Article
3
Retiring well for today's physician continues to evolve.
- Published in:
- Ocular Surgery News, 2024, v. 42, n. 10, p. 30
- By:
- Publication type:
- Article
4
We don't know what dry eye is, but we sure have a lot of ways to treat it.
- Published in:
- Ocular Surgery News, 2024, v. 42, n. 10, p. 29
- By:
- Publication type:
- Article
5
FDA approves Ultomiris for neuromyelitis optica spectrum disorder.
- Published in:
- Ocular Surgery News, 2024, v. 42, n. 10, p. 28
- By:
- Publication type:
- Article
6
INDUSTRY PIPELINE.
- Published in:
- Ocular Surgery News, 2024, v. 42, n. 10, p. 26
- Publication type:
- Article
7
30-DAY STOCK TRENDS.
- Published in:
- Ocular Surgery News, 2024, v. 42, n. 10, p. 26
- Publication type:
- Article
8
Terry Kim, MD, to serve as chief medical officer, head of global medical safety at Alcon.
- Published in:
- Ocular Surgery News, 2024, v. 42, n. 10, p. 26
- Publication type:
- Article
9
Evolutionary mindset needed for refractive surgery.
- Published in:
- Ocular Surgery News, 2024, v. 42, n. 10, p. 25
- By:
- Publication type:
- Article
10
Phaco plus MIGS helps improve quality of life, prevent visual field loss.
- Published in:
- Ocular Surgery News, 2024, v. 42, n. 10, p. 24
- By:
- Publication type:
- Article
11
Consider pros, cons of presbyopia eye drops.
- Published in:
- Ocular Surgery News, 2024, v. 42, n. 10, p. 22
- By:
- Publication type:
- Article
12
Progress has been slow in stem cell therapy for retinal diseases.
- Published in:
- Ocular Surgery News, 2024, v. 42, n. 10, p. 21
- By:
- Publication type:
- Article
13
Dry eye and the surgical patient: This is still a thing.
- Published in:
- Ocular Surgery News, 2024, v. 42, n. 10, p. 16
- By:
- Publication type:
- Article
14
Equity: Buyback rights, forfeiture and vesting.
- Published in:
- Ocular Surgery News, 2024, v. 42, n. 10, p. 8
- By:
- Publication type:
- Article
15
Multifocal IOLs not recommended.
- Published in:
- Ocular Surgery News, 2024, v. 42, n. 10, p. 14
- By:
- Publication type:
- Article
16
Are premium IOLs suitable for patients with Fuchs' endothelial dystrophy?
- Published in:
- Ocular Surgery News, 2024, v. 42, n. 10, p. 14
- By:
- Publication type:
- Article
17
Ocular Surface Disease and Eyelid Health: Seeing Eye to Eye.
- Published in:
- Ocular Surgery News, 2024, v. 42, n. 10, p. 12
- Publication type:
- Article
18
Several suitable options.
- Published in:
- Ocular Surgery News, 2024, v. 42, n. 10, p. 14
- By:
- Publication type:
- Article
19
Ophthalmologist-led practice may be best model for ocular surface disease treatment.
- Published in:
- Ocular Surgery News, 2024, v. 42, n. 10, p. 3
- By:
- Publication type:
- Article
20
What is the most rewarding part about treating dry eye disease?
- Published in:
- Ocular Surgery News, 2024, v. 42, n. 10, p. 11
- By:
- Publication type:
- Article
21
It is time to rethink cataract surgery refractive targets.
- Published in:
- Ocular Surgery News, 2024, v. 42, n. 10, p. 6
- By:
- Publication type:
- Article
22
Video Journal of Cataract, Refractive, and Glaucoma Surgery celebrates 40-year anniversary.
- Published in:
- Ocular Surgery News, 2024, v. 42, n. 10, p. 5
- By:
- Publication type:
- Article
23
Frugal innovation key to cataract surgery sustainability.
- Published in:
- Ocular Surgery News, 2024, v. 42, n. 10, p. 1
- By:
- Publication type:
- Article
24
Dry eye care navigates growing physician shortage.
- Published in:
- Ocular Surgery News, 2024, v. 42, n. 10, p. 1
- By:
- Publication type:
- Article